Business & Industry
Sanofi Advances T1D Treatment with Tzield FDA Approval in US
The US Food and Drug Administration (FDA) has granted accelerated approval to Sanofi’s Tzield (teplizumab-mzwv) for children aged eight to 17 years who have recently been diagnosed with stage 3 type 1 diabetes (T1D). The decision allows the therapy...
Business & Industry
Celltrion Expands Oncology Biosimilars Portfolio in Vietnam
Celltrion has strengthened its footprint in Vietnam by introducing two oncology biosimilars, further expanding its portfolio in one of Southeast Asia’s rapidly growing pharmaceutical markets. The company announced that commercial sales of Truxima (rituximab), used in the treatment of...
News
How Pharmaceutical Safety Standards Help Protect Elderly Patients in Long-Term Care Facilities
As the global population ages, healthcare systems are facing new challenges in delivering safe and effective care to elderly patients. Long-term care facilities, nursing homes, and assisted living communities are now responsible for managing increasingly complex medical needs, including...
News
Best Pharma Shredder Manufacturer
We have a very wide range of pharma shredders developed over the years from practical shredding experience, these machines are manufactured in standard as well as GMP versions, The machines are carefully manufactured in our factory in Mumbai ,...
News
How Oral Semaglutide Extends GLP-1 Delivery Into Weight Management
The development of oral semaglutide (for example, oral Wegovy) for weight management matters because it addresses a problem that goes well beyond patient convenience. Injectable incretin therapies, including semaglutide and tirzepatide pens, have dominated the
weight-management category in recent years,...
Business & Industry
Sigma Healthcare Pursues Potential Boots Acquisition Deal
Australia’s Sigma Healthcare has confirmed that it is participating in discussions regarding a possible acquisition of Boots, the UK health and beauty retailer, in a transaction reportedly valued at up to $10 billion. The company acknowledged its interest after...
Business & Industry
MHRA Launches AI Sandbox to Accelerate Drug Development
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced the launch of a new AI Sandbox programme designed to explore how artificial intelligence can strengthen medicines safety, improve risk prediction and support faster development of new treatments. Announced...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read